Eagle Health Investments LP Tandem Diabetes Care Inc Transaction History

Eagle Health Investments LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $2.54 Million - $4.47 Million	-105,200 Reduced 24.72%	320,325 $7.86 Million
Q1 2023 May 12, 2023	SELL	$35.86 - $46.5 $5.92 Million - $7.67 Million	-164,975 Reduced 27.94%	425,525 $17.3 Million
Q4 2022 Feb 13, 2023	BUY	$35.49 - $56.15 $14 Million - $22.1 Million	394,100 Added 200.66%	590,500 $26.5 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $8.59 Million - $13.5 Million	196,400 New	196,400 $9.4 Million

362

73.7M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.32B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

Stay updated on Eagle Health Investments LP with notifications on news.